These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 26036338)
1. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338 [TBL] [Abstract][Full Text] [Related]
2. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204 [TBL] [Abstract][Full Text] [Related]
3. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome. Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410 [TBL] [Abstract][Full Text] [Related]
4. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Vindigni SM; Kaz AM Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911 [TBL] [Abstract][Full Text] [Related]
5. Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent. Subramonian A; Smith D; Dicks E; Dawson L; Borgaonkar M; Etchegary H Per Med; 2020 Sep; 17(5):373-387. PubMed ID: 32875945 [No Abstract] [Full Text] [Related]
6. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice. Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326 [TBL] [Abstract][Full Text] [Related]
7. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359 [TBL] [Abstract][Full Text] [Related]
8. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220 [TBL] [Abstract][Full Text] [Related]
10. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community. Schofield L; Goldblatt J; Iacopetta B Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening. Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634 [TBL] [Abstract][Full Text] [Related]
12. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience. Kidambi TD; Blanco A; Myers M; Conrad P; Loranger K; Terdiman JP Dig Dis Sci; 2015 Aug; 60(8):2463-9. PubMed ID: 24903654 [TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409 [TBL] [Abstract][Full Text] [Related]
14. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey. Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327 [TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer. Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831 [TBL] [Abstract][Full Text] [Related]
17. Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families. Burton-Chase AM; Hovick SR; Peterson SK; Marani SK; Vernon SW; Amos CI; Frazier ML; Lynch PM; Gritz ER Clin Genet; 2013 Mar; 83(3):215-20. PubMed ID: 23414081 [TBL] [Abstract][Full Text] [Related]
18. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome. Newton K; Green K; Lalloo F; Evans DG; Hill J Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040 [TBL] [Abstract][Full Text] [Related]
19. Recording of family history is associated with colorectal cancer stage. Kessels K; de Groot NL; Fidder HH; Timmer R; Stolk MF; Offerhaus GJ; Siersema PD; Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):482-7. PubMed ID: 23470269 [TBL] [Abstract][Full Text] [Related]
20. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project. Patel SG; Ahnen DJ; Kinney AY; Horick N; Finkelstein DM; Hill DA; Lindor NM; MaCrae F; Lowery JT Am J Gastroenterol; 2016 Feb; 111(2):285-93. PubMed ID: 26856748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]